BMC Cancer

Table 1 Association between B4GALT1 expression and patient characteristics

From: B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients

Characteristic	Training set (n = 142)					Validation set (n = 112)
	Patients		B4GALT1 expression			Patients		B4GALT1 expression
	NO.	%	Low	High	P	NO.	%	Low	High	P
Age, years					0.614					0.763
Mean ± SD	62.4 ± 10.8		61.8 ± 10.9	62.7 ± 10.8		61.5 ± 8.7		61.8 ± 9.7	61.3 ± 7.6
Range, median	30–82,62		34–82,62	30–82,62		35–81,62		35–81,62	46–75,61
Gender					0.925					0.581
Male	118	83.1	45	73		97	86.6	48	49
Female	24	16.9	10	14		15	13.4	9	6
Tumor size, cm					0.053					0.411
Mean ± SD	3.8 ± 1.9		4.2 ± 2.1	3.6 ± 1.7		3.8 ± 1.8		3.9 ± 2.0	3.7 ± 1.6
Range	0.5–10.0		1.0–10.0	0.5–8.0		0.8–9.5		0.8–9.5	1.3–9.0
pT stage					0.971					0.720
T2	68	47.9	27	41		49	43.8	27	22
T3	48	33.8	18	30		49	43.8	23	26
T4	26	18.3	10	16		14	12.4	7	7
Grade					0.017					0.950
low	24	16.9	15	9		11	9.8	6	5
high	118	83.1	40	78		101	90.2	51	50
LVI					0.157					0.741
absent	53	37.3	25	28		78	69.6	41	37
present	89	62.7	30	59		34	30.4	16	18
CCI					0.116					0.263
≤ 1	47	33.1	23	24		44	39.3	19	25
≥ 2	95	66.9	32	63		68	60.7	38	30

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com